Top Growth Trends in the Artificial Intelligence (AI) In Respiratory Diseases Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the artificial intelligence (ai) in respiratory diseases market right now?
The market for artificial intelligence (AI) in respiratory illness has been expanding firmly over the past few years. It is projected to increase from $7.66 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.1%. The expansion during the historic period can be credited to factors such as heightened government regulations, growing concerns about the environment, an increasing elderly population, a surge in patient-focused healthcare strategies, and a rise in the development of healthcare infrastructure.
How fast Is the artificial intelligence (ai) in retail market expected to grow, and what’s its future value?
The market size of artificial intelligence (AI) in the area of respiratory diseases is projected to experience significant growth in the forthcoming years. It is anticipated to reach $9.85 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this predicted growth during the forecast period include an increasing number of respiratory disease cases, a heightened demand for early detection and diagnosis, escalating environmental pollution, rising healthcare spending, and research and development efforts. Futures trends predicted for this period encompass technological innovations, drug discovery and enhancement, individualized treatment strategies, the adoption of telemedicine and remote patient monitoring.
Get your artificial intelligence (ai) in respiratory diseases market report here!
What are the leading drivers of growth in the artificial intelligence (ai) in respiratory diseases market?
The escalating issue of environmental contamination is predicted to boost the expansion of artificial intelligence (AI) in the respiratory disease market. This type of pollution occurs when the rate of contaminants or energy added to the environment outpaces the rate at which they can be neutralized or stored safely. By providing real-time monitoring, customized risk evaluations, evidence-based decision-making, and creative solutions, AI in respiratory diseases could markedly mitigate the effects of environmental contamination on respiratory health for both individuals and communities. For example, the US Energy Information Administration, a government agency, reported that CO2 emissions were 35.72 billion metric tons in 2021 and rose to 38.50 billion metric tons in 2022. Consequently, the escalating environmental pollution is spurring the expansion of artificial intelligence (AI) in the respiratory disease market.
What are the key segments defining the artificial intelligence (ai) in respiratory diseases market?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
Who are the key players steering the development of the artificial intelligence (ai) in respiratory diseases market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
What emerging trends are influencing the growth of the artificial intelligence (ai) in respiratory diseases market?
Leading corporations in the respiratory diseases market using artificial intelligence (AI) are pushing the boundaries by creating groundbreaking products like N-Tidal devices that track a patient’s tidal breathing. These devices help gauge the amount of air transferred during normal respiration, thereby offering crucial insights into lung functionality. For instance, TidalSense, a respiratory technology firm based in the UK, unveiled its regulated AI technology, N-Tidal, in August 2023. This technology, designed for chronic obstructive pulmonary disease (COPD) diagnosis and administration, marries the CO2 sensor data from N-Tidal with an AI platform to monitor variations in lung functionality. It aims to enhance both the diagnosis and management of this respiratory condition. Clinical trials have reaffirmed the high precision of this technology, which is predicted to revolutionize the diagnostic procedure for respiratory diseases. Its introduction marks a pivotal step in applying AI to assess respiratory diseases, offering a more convenient and effective substitute to current diagnostic trials.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792
Which regions are most influential in expanding the artificial intelligence (ai) in respiratory diseases market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Artificial Intelligence in Healthcare Global Market Report 2024
Artificial Intelligence Services Global Market Report 2024
Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
